Thomas Jefferson University Hospital

symplr Customers Top the 2023 CHIME Digital Health Most Wired List

Retrieved on: 
Tuesday, December 19, 2023

HOUSTON, Dec. 19, 2023 /PRNewswire-PRWeb/ -- symplr®, a leading provider of enterprise healthcare operations software, congratulates its customers for achieving Level 10 status, the highest recognition in the acute care category, on the 2023 Digital Health Most Wired list by the College of Healthcare Information Management Executives (CHIME). All organizations are symplr customers, recognized for demonstrating an outstanding record of leveraging healthcare information technologies (HIT) within a visionary corporate strategy.

Key Points: 
  • HOUSTON, Dec. 19, 2023 /PRNewswire-PRWeb/ -- symplr ®, a leading provider of enterprise healthcare operations software, congratulates its customers for achieving Level 10 status, the highest recognition in the acute care category, on the 2023 Digital Health Most Wired list by the College of Healthcare Information Management Executives ( CHIME ).
  • - Nicole Rogas, President of symplr
    The annual CHIME Digital Health Most Wired survey and recognition program offers essential insights into how healthcare organizations worldwide are using HIT, offering benchmarking data and trending profiles of digital health for comparisons across healthcare organizations.
  • "Having a well-thought-out digital health strategy is critical to driving efficiencies within a healthcare system," said Nicole Rogas, President of symplr.
  • The following symplr customers are part of the largest cohort of Level 10 status hospitals ever honored in the CHIME Most Wired survey's 24-year history: Baptist Health – Jacksonville, Cedars-Sinai, Geisinger Health, Intermountain Health, Jefferson Health and Thomas Jefferson University Hospital, Jersey City Medical Center, Mayo Clinic, Orlando Health, RWJBarnabas Health, RWJ University Hospital Hamilton, University Health, UNC Health, UCHealth, UPMC, Virtua Health System, and West Virginia University Health System.

Urology Care Foundation Announces Recipient of the 2023 Rising Stars in Urology Research Award

Retrieved on: 
Tuesday, November 14, 2023

BALTIMORE, Nov. 14, 2023 /PRNewswire/ -- The American Urological Association (AUA) and the Urology Care Foundation—the official foundation of the AUA—today announced Kymora Scotland, MD, PhD, as the latest recipient of the Rising Stars in Urology Research Award.

Key Points: 
  • BALTIMORE, Nov. 14, 2023 /PRNewswire/ -- The American Urological Association (AUA) and the Urology Care Foundation—the official foundation of the AUA—today announced Kymora Scotland, MD, PhD, as the latest recipient of the Rising Stars in Urology Research Award.
  • The Rising Stars in Urology Research Award program was established in 2005 to encourage recipients to contribute to urology as surgical specialists and scientists investigating causes, prevention, treatment and cures that will improve patient's lives.
  • "Every year, the research showcased for the Rising Stars in Urology Research Award recipients become increasingly exceptional and pioneering, and this year is no exception," said Steven Kaplan, MD, chair of the AUA Research Council.
  • For more information on the Rising Stars in Urology Research Award, visit: https://www.auanet.org/research-and-data/research-awards/aua-funding/ris...

BigBear.ai Expands Partnership with Thomas Jefferson University Hospital

Retrieved on: 
Tuesday, October 31, 2023

“BigBear.ai is thrilled to expand its work with Thomas Jefferson University Hospital,” said Greg Goldwater, Chief Growth Officer at BigBear.ai.

Key Points: 
  • “BigBear.ai is thrilled to expand its work with Thomas Jefferson University Hospital,” said Greg Goldwater, Chief Growth Officer at BigBear.ai.
  • “Because BigBear’s Predictive AI platform can effectively predict the future through event simulation, it’s a game-changer for hospital systems looking to roll out strategic growth plans.
  • We look forward to our next phase of collaboration that will ultimately drive better patient care and outcomes.”
    During a long-term strategic planning exercise with Thomas Jefferson University Hospital, Future Flow RX tested likely upstream and downstream outcomes based on predicted hospital volume growth and demand shifts.
  • As a result, Jefferson was then able to optimize its master facility plan to meet future patient needs best.

Peptilogics Reports Positive 180-Day Top-Line Interim Data From Phase 1B Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI)

Retrieved on: 
Tuesday, September 19, 2023

Peptilogics, a clinical-stage biotechnology company, today announced new top-line interim data for PLG0206 in periprosthetic joint infection (PJI) patients from their ongoing Phase 1b trial.

Key Points: 
  • Peptilogics, a clinical-stage biotechnology company, today announced new top-line interim data for PLG0206 in periprosthetic joint infection (PJI) patients from their ongoing Phase 1b trial.
  • At 180-days following treatment with PLG0206 administered during a DAIR (Debridement, Antibiotics, and Implant Retention) surgery, no treatment-related serious adverse events were reported in either cohort.
  • One recurrence was observed in the trial (one of 14 patients, 7%), which was in the Low Dose cohort at Day-180; no recurrences were observed in the High-Dose cohort.
  • “Most of the patients in this trial have a very high risk of failure due to their comorbidities including obesity, diabetes, and prior joint surgeries, making them some of the hardest patients to treat.

Xylazine Has Spread to Every Region of the Country, Millennium Health Signals Report™ Shows

Retrieved on: 
Thursday, September 14, 2023

This analysis of the nationwide spread of xylazine is the most current and substantiative to date since xylazine use rose to prominence.

Key Points: 
  • This analysis of the nationwide spread of xylazine is the most current and substantiative to date since xylazine use rose to prominence.
  • View the full release here: https://www.businesswire.com/news/home/20230913825526/en/
    Geographical Analysis of Xylazine Use Among Individuals Who Use Fentanyl - Rate by U.S. Census Divisions.
  • The Millennium Health Signals Report: Zeroing in on Xylazine: The First 100 Days After U.S.
  • Millennium Health analyzed Xylazine UDT positivity in the fentanyl using population by U.S. Census Division.

Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team

Retrieved on: 
Tuesday, September 5, 2023

WARSAW, Ind., Sept. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key updates to the Company's Executive Leadership Team. Wilfred van Zuilen has been promoted to Group President, EMEA; Mark Bezjak was promoted to President of the Americas; and Chief Science, Technology and Innovation Officer Nitin Goyal, M.D. has been appointed to the Executive Leadership Team, all reporting directly to President and Chief Executive Officer Ivan Tornos.

Key Points: 
  • Appointed to Executive Leadership Team
    WARSAW, Ind., Sept. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key updates to the Company's Executive Leadership Team.
  • has been appointed to the Executive Leadership Team, all reporting directly to President and Chief Executive Officer Ivan Tornos.
  • "The expansion of Zimmer Biomet's Executive Leadership Team coincides with our renewed focus on commercial execution and innovation to drive the Company forward," said Mr. Tornos.
  • Wilfred Van Zuilen Promotion to Group President, EMEA
    Mr. van Zuilen joined Zimmer Biomet in June 2021 as President, EMEA.

Jefferson Names Keith Leaphart, DO, MBA, New Humana Chief Health Equity and Community Impact Officer

Retrieved on: 
Wednesday, August 23, 2023

PHILADELPHIA, Aug. 23, 2023 /PRNewswire/ -- Today, Jefferson announced that Keith Leaphart, DO, MBA, has been named Enterprise Executive Vice President (EVP) and Humana Chief Health Equity and Community Impact Officer, effective Monday, September 11, 2023. His oversight includes Thomas Jefferson University, Jefferson Health and Jefferson Health Plans.

Key Points: 
  • "I am honored to be back at Jefferson to focus on expanding its community impact and its extensive efforts to improve health equity throughout our region," said Keith Leaphart, DO, MBA, Executive Vice President and Humana Chief Health Equity and Community Impact Officer.
  • I look forward to joining the team and driving innovative solutions that advance health equity and improve community health."
  • Humana's endowment established three priority positions at Jefferson: Humana Deanship in the College of Population Health , Humana Professorship of Community Health and Equity, and Humana Chief Health Equity and Community Impact Officer, each focused on improving population health and advancing health equity in the region.
  • "Dr. Leaphart's leadership and expertise in advancing health equity and community health will be a critical asset to Jefferson and Humana in our partnership to improve health outcomes in greater Philadelphia and beyond," said J. Nwando Olayiwola, MD, MPH, Chief Health Equity Officer & Senior VP at Humana.

Aramark Chefs Earn Prestigious ProChef® Certification From the Culinary Institute of America

Retrieved on: 
Wednesday, August 16, 2023

Aramark (NYSE: ARMK), the largest U.S.-based food service company, is pleased to announce 16 chefs have graduated from the prestigious ProChef® certification program at The Culinary Institute of America (CIA).

Key Points: 
  • Aramark (NYSE: ARMK), the largest U.S.-based food service company, is pleased to announce 16 chefs have graduated from the prestigious ProChef® certification program at The Culinary Institute of America (CIA).
  • View the full release here: https://www.businesswire.com/news/home/20230816263978/en/
    Aramark announced 16 chefs, including these chefs from its Collegiate Hospitality business, have graduated from the prestigious ProChef® certification program at The Culinary Institute of America (CIA).
  • The ProChef certification program is a three-tiered, comprehensive professional development and culinary proficiency program.
  • Nearly 300 Aramark chefs have received ProChef certification since Aramark first enrolled in the program in 2008.

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

Retrieved on: 
Thursday, July 20, 2023

MOUNTAIN VIEW, Calif., July 20, 2023 /PRNewswire/ -- AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced a partnership with the Jefferson Narcotic Addiction Rehabilitation Program (NARP) and Thomas Jefferson University Hospital in Philadelphia to evaluate the benefits of QTc monitoring with KardiaMobile 6L for patients receiving methadone maintenance therapy for opioid use disorder.

Key Points: 
  • MOUNTAIN VIEW, Calif., July 20, 2023 /PRNewswire/ -- AliveCor , the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced a partnership with the Jefferson Narcotic Addiction Rehabilitation Program (NARP) and Thomas Jefferson University Hospital in Philadelphia to evaluate the benefits of QTc monitoring with KardiaMobile 6L for patients receiving methadone maintenance therapy for opioid use disorder.
  • In the six-month pilot study, healthcare professionals will use KardiaMobile 6L, the only medical-grade, six-lead personal ECG device that is FDA-cleared to measure QTc intervals, to detect QT prolongation, a potentially dangerous side effect associated with certain medications like methadone.
  • "We are excited to partner with Thomas Jefferson University Hospital on this important study that will illuminate the benefits of real-time QTc interval monitoring with KardiaMobile 6L on patients' outcomes and their treatment experience," said Patricia Baran, Senior Vice President, Enterprise North America & Biopharma Worldwide.
  • "We look forward to assessing how efficient QTc monitoring with KardiaMobile 6L increases compliance with guideline recommendations, improves the patient experience, enhances treatment, and allows for interdepartmental collaboration," said Daniel Frisch, MD, Associate Professor of Medicine Electrophysiology Section, Thomas Jefferson University Hospital.

NRI Celebrates the Successful Integration of Velrada

Retrieved on: 
Wednesday, July 12, 2023

Nomura Research Institute (NRI) Australia & New Zealand today announced that Microsoft solutions partner Velrada has been integrated into NRI ANZ from July 1, 2023.

Key Points: 
  • Nomura Research Institute (NRI) Australia & New Zealand today announced that Microsoft solutions partner Velrada has been integrated into NRI ANZ from July 1, 2023.
  • NRI ANZ CEO Dean Langenbach said: “Velrada has had an impressive year, and we are delighted to welcome it as a fully-fledged member of the NRI family.
  • “Since acquiring Velrada, its revenue figures have grown by 26 per cent, while its staff numbers have increased by 35 per cent.
  • Mr Fuller said: “Velrada is a Microsoft Gold Partner and the outlook for its Microsoft opportunities remains strong.